Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Brammer Bio Launches New cGMP Facility | Contract Pharma

What are you searching for?

Sign in
Breaking News

Brammer Bio Launches New cGMP Facility

The Cambridge, Massachusetts site will focus on manufacturing for gene therapy products

By: Betsy Louda

, Contract Pharma

Brammer Bio, a cell and gene therapy contract development and manufacturing organization (CDMO), has launched its newly renovated cGMP manufacturing site in Cambridge, MA for gene therapy products. The 66,000 square-foot facility houses state-of-the-art equipment in cleanroom suites designed to accommodate a broad-range of gene therapy manufacturing process technologies.

 

“Our Cambridge site underwent a remarkable transformation,” said Mark Bamforth, president and chief executive officer of Brammer. “We converted the former biologics manufacturing space that once produced some of the first antibody-based therapies into a facility that now produces leading edge gene therapy products using a variety of manufacturing platforms.”

 

This comes after Brammer’s January 2017 acquisition of the site from Biogen. Today, the facility includes multiple drug substance suites able to support large-scale adherent and stirred tank production,  quality control laboratories, process development space, and more. 

 

The site’s launch aims to demonstrate Brammer’s end-to-end CDMO services from early phase process development through commercial manufacturing.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics